| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |